Redefine metabolic health with cutting-edge triple agonist technology.
Retatrutide is an investigational peptide that acts as a triple agonist, targeting GLP-1, GIP, and glucagon receptors. This innovative mechanism supports advanced research in weight loss, metabolic health, and insulin sensitivity. Early clinical studies suggest that Retatrutide may offer enhanced benefits over single-receptor agonists, making it a standout in research focused on obesity and metabolic disorders.
Product Highlights:
-
Concentration: 10mg per vial
-
Purity: >99% (HPLC Verified)
-
Form: Lyophilized powder for optimal stability
-
Storage: Store in a cool, dry place. Reconstitute with bacteriostatic water before use.
-
Research Use Only: Not for human consumption, medical, or veterinary use.
Why Choose Retatrutide?
-
Supports weight loss and metabolic health research
-
Enhances insulin sensitivity and glucose regulation
-
Promotes multi-receptor activation for advanced studies
-
Ideal for obesity and type 2 diabetes research applications
š Advance Your Research with Cutting-Edge Metabolic Solutions!
Add Retatrutide to your laboratory for groundbreaking studies in weight management and metabolic optimization.
ā ļø Legal Compliance Notice:
This product is intended strictly for research and laboratory use only. It is not approved by the FDA for human or veterinary use. All handling and application must be performed by qualified professionals. Misuse or improper handling may lead to health risks. By purchasing this product, you acknowledge and accept these terms.
